Related Experiment Video

Updated: Mar 6, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

Small molecule selectively suppresses MYC transcription in cancer cells

Claire Bouvard1, Sang Min Lim1, John Ludka1

  • 1California Institute for Biomedical Research, La Jolla, CA 92037.

Proceedings of the National Academy of Sciences of the United States of America
|March 16, 2017
PubMed

Insights

Stauprimide, an anticancer drug, effectively inhibits MYC transcription in various cancer cells by blocking NME2 nuclear localization. This targeted approach suppressed tumor growth in preclinical models, offering a new strategy for MYC-dependent cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • The oncogene MYC is crucial for tumor initiation and progression.
  • Stauprimide is a staurosporine analog with known effects on embryonic stem cell differentiation.
  • Inhibiting MYC transcription is a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To investigate the potential of stauprimide as an anticancer agent.
  • To determine if stauprimide can suppress MYC transcription in cancer cell lines.
  • To explore the mechanism of stauprimide's action on MYC regulation.

Main Methods:

  • Testing stauprimide in various cancer cell lines.
  • Analyzing NME2 nuclear localization in renal cancer cells.
  • Performing gene expression analysis of MYC target genes.
  • Evaluating tumor growth inhibition in rodent xenograft models.

Main Results:

  • Stauprimide suppressed MYC transcription across distinct cancer cell lines.
  • Stauprimide inhibited nuclear localization of the MYC transcription factor NME2.
  • Selective down-regulation of MYC target genes was observed.
  • Stauprimide administration led to significant inhibition of tumor growth in vivo.

Conclusions:

  • Stauprimide demonstrates anticancer potential by selectively targeting MYC transcription.
  • Inhibition of NME2 nuclear localization is a key mechanism of stauprimide's action.
  • Stauprimide represents a promising therapeutic strategy for MYC-dependent tumors.
Keywords:
MYCNME2cancernuclear localizationstauprimide

More Related Videos

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

10.0K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.9K

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K